HAVN Life Enters into Agreement to Acquire Clinical Stage IP for Development of LSD-Derived API for Cluster Headaches May 17, 2021
MindMed Bolsters Management Team, Appoints Peter Mack PhD as Vice President of Pharmaceutical Development May 13, 2021
Numinus Wellness and Optimi Health Submit All-Natural Psilocybin Extract to Health Canada for Pre-Clinical Trial… May 11, 2021
PharmaTher Expands Patent Portfolio for Ketamine and Repurposing of Psychedelics with panaceAI™ Apr 27, 2021
